Remarkably, Exact Sciences Corp. reaches most of the U.S. patients who are the recommended age to get screened with its Cologuard. Already, 62 percent of that population get the only FDA-approved, noninvasive, DNA-based colorectal screening test, which simply requires patients to mail in a fecal sample for testing.